Meet the RespiRx™ Qnovia’s™ combination drug product designed to be the world’s first nicotine nebuliser NRT (Nicotine Replacement Therapy) for smokers trying to quit smoking.

Every year over 20 Million smokers try to quit smoking and most fail. While technology has advanced, smokers trying to quit today are left behind with no breakthrough therapies made available to them in the last 15 years. Smokers know existing therapies aren’t successful which is why today the number one way smokers try to quit is still “cold turkey.” Even with therapies, over 90% of smokers who try to quit, fail. Qnovia’s™ mission is to change that with our planned application to the MHRA in the UK to deliver a new standard in convenience and efficacy for smokers trying to quit.

The RespiRx™ is an easy to use, zero-maintenance cartridge-based medical grade inhaled drug delivery system that will be available over the counter or via health care professionals to help smokers finally quit smoking. Each cartridge is filled aseptically and contains both our proprietary aerosol generating technology and the drug product.